Home > Boards > US Listed > Medical - Drugs > Ironwood Pharmaceuticals Inc (IRWD)

How about your long position here? 1/3

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
brownsfan407 Member Profile
 
Followed By 6
Posts 604
Boards Moderated 0
Alias Born 04/14/13
160x600 placeholder
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/16/2019 4:54:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:15:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:14:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:13:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:12:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2019 8:01:21 AM
Ironwood Pharmaceuticals to Highlight IW-3718 and Linaclotide Data at Digestive Disease Week® 2019 Business Wire - 5/9/2019 8:00:00 AM
Ironwood Pharmaceuticals to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference Business Wire - 5/7/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:25:34 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/3/2019 4:10:12 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2019 4:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 7:46:53 AM
Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operatio... Business Wire - 5/2/2019 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 5:26:57 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/26/2019 3:18:23 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/26/2019 3:17:12 PM
Ironwood Pharmaceuticals to Host First Quarter 2019 Investor Update Call Business Wire - 4/18/2019 4:05:00 PM
Ironwood Pharmaceuticals Announces Adjustment of Conversion Rate for its 2.25% Convertible Senior Notes due 2020 Business Wire - 4/16/2019 4:02:00 PM
New Research: Key Drivers of Growth for Ironwood Pharmaceuticals, State Street, CMS Energy, Virtus Investment Partners, Capst... GlobeNewswire Inc. - 4/16/2019 8:45:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/12/2019 5:17:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2019 4:46:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/4/2019 4:48:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2019 7:08:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2019 6:48:04 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/3/2019 6:46:26 PM
brownsfan407   Wednesday, 06/24/15 06:46:55 PM
Re: chemist99 post# 217
Post # of 252 
How about your long position here? 1/3 the diarrhea rate for plecanatide, and filing NDA in November. Has to severely stunt the growth here. What is the adage, the market is forward looking? However, maybe you can clarify. The guy who took IRWD through the NDA process, does he still work for you?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist